Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
technetium Tc 99m red blood cells
- Development stage
- Approved
- Lead developer
- Curium
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
Ultratag (Ultratag RBC) is a diagnostic radiopharmaceutical kit used for the in vitro preparation of technetium Tc 99m-labeled red blood cells. Developed by Mallinckrodt (now Curium), the kit contains stannous chloride dihydrate, sodium citrate dihydrate, and dextrose. The stannous ion acts as a reducing agent, allowing the radioactive isotope technetium-99m to bind to hemoglobin within the patient's red blood cells. Once re-injected, these labeled cells serve as a blood pool imaging agent, facilitating diagnostic procedures such as cardiac gated equilibrium imaging (MUGA scans), first-pass radionuclide angiography, and the localization of gastrointestinal bleeding sites.
- Brand names
- UltratagUltratag RBC
- Other names
- Tc-99m RBCTc99m RBCTc 99m RBCTechnetium Tc 99m-labeled Red Blood Cells
Beyond the preview
Go deeper on technetium Tc 99m red blood cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on technetium Tc 99m red blood cells.